• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region
Dermatology

World Congress on Itch (WCI) 2023 | Miami

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.
Sarina Elmariah
Brian Kim
MD, PhD
Sarina Elmariah +1 more
See post-event materials
Past event
7November2023
Location
JW Marriot
1109 Brickell Ave 33131 Miami, FL United States

Learning objectives

  • Describe the role of type 2 inflammation in the development of itch in AD, PN, and CSU
  • Discuss the contribution of neuroimmune axis dysregulation to the development of itch in AD, PN, and CSU
  • Explore disease-specific combinations of type 2 inflammatory mediators that may underlie disease-specific itch in AD, PN, and CSU

Description

The chronic skin conditions atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) have distinct clinical signs but share the common, debilitating symptom of itch. In AD, PN, and CSU, type 2 inflammation and a dysregulated neuroimmune axis underlie itch pathophysiology. This symposium explores the shared mechanisms of itch across these diseases, as well as the distinct ways itch manifests in each condition. Understanding the pathomechanisms of itch will help to address the substantial burden of these chronic pruritic conditions.

Location

JW Marriot
1109 Brickell Ave 33131 Miami, FL United States
Tags
neuroimmune mechanisms
MAT-US-2309780 v1.0 - P Expiration Date: 02/12/2026

Speakers

Dermatology
MD, PhD

Sarina Elmariah

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

Dermatology
MD

Brian Kim

Professor, Vice Chair of Research, and Site Chair of Mount Sinai West, Icahn School of Medicine, NY, US